Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Toan C Ong"'
Autor:
David J. Douin, Adane F. Wogu, Laurel E. Beaty, Nichole E. Carlson, Tellen D. Bennett, Neil R. Aggarwal, David A. Mayer, Toan C. Ong, Seth Russell, Jeffrey Steele, Jennifer L. Peers, Kyle C. Molina, Matthew K. Wynia, Adit A. Ginde
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Neutralizing monoclonal antibodies (mAbs) are highly effective in reducing hospitalization and mortality among early symptomatic COVID-19 patients in clinical trials and real-world data. While resistance to some mAbs has since eme
Externí odkaz:
https://doaj.org/article/9243363dc9f34305a5f57b6c977b0775
Autor:
Katherine Adams, John J. Riddles, Elizabeth A.K. Rowley, Shaun J. Grannis, Manjusha Gaglani, Bruce Fireman, Emily Hartmann, Allison L. Naleway, Edward Stenehjem, Alexandria Hughes, Alexandra F. Dalton, Karthik Natarajan, Kristin Dascomb, Chandni Raiyani, Stephanie A. Irving, Chantel Sloan-Aagard, Anupam B. Kharbanda, Malini B. DeSilva, Brian E. Dixon, Toan C. Ong, Jean Keller, Monica Dickerson, Nancy Grisel, Kempapura Murthy, Juan Nanez, William F. Fadel, Sarah W. Ball, Palak Patel, Julie Arndorfer, Mufaddal Mamawala, Nimish R. Valvi, Margaret M. Dunne, Eric P. Griggs, Peter J. Embi, Mark G. Thompson, Ruth Link-Gelles, Mark W. Tenforde
Publikováno v:
The Lancet Regional Health. Americas, Vol 23, Iss , Pp 100530- (2023)
Summary: Background: Understanding the usefulness of additional COVID-19 vaccine doses—particularly given varying disease incidence—is needed to support public health policy. We characterize the benefits of COVID-19 booster doses using number nee
Externí odkaz:
https://doaj.org/article/8acf40956eed4175ada422754f35470d
Autor:
Ruth Link-Gelles, Zachary A. Weber, Sarah E. Reese, Amanda B. Payne, Manjusha Gaglani, Katherine Adams, Anupam B. Kharbanda, Karthik Natarajan, Malini B. DeSilva, Kristin Dascomb, Stephanie A. Irving, Nicola P. Klein, Shaun J. Grannis, Toan C. Ong, Peter J. Embi, Margaret M. Dunne, Monica Dickerson, Charlene McEvoy, Julie Arndorfer, Allison L. Naleway, Kristin Goddard, Brian E. Dixon, Eric P. Griggs, John Hansen, Nimish Valvi, Morgan Najdowski, Julius Timbol, Colin Rogerson, Bruce Fireman, William F. Fadel, Palak Patel, Caitlin S. Ray, Ryan Wiegand, Sarah Ball, Mark W. Tenforde
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 72:579-588
Autor:
Matthew K. Wynia, Laurel E. Beaty, Tellen D. Bennett, Nichole E. Carlson, Christopher B. Davis, Bethany M. Kwan, David A. Mayer, Toan C. Ong, Seth Russell, Jeffrey D. Steele, Heather R. Stocker, Adane F. Wogu, Richard D. Zane, Ronald J. Sokol, Adit A. Ginde
Publikováno v:
Chest. 163:1061-1070
Neutralizing monoclonal antibodies (mAbs) were authorized for the treatment of COVID-19 outpatients based on clinical trials completed early in the pandemic, which were underpowered for mortality and subgroup analyses. Real-world data studies are pro
Autor:
Mark W. Tenforde, Zachary A. Weber, Karthik Natarajan, Nicola P. Klein, Anupam B. Kharbanda, Edward Stenehjem, Peter J. Embi, Sarah E. Reese, Allison L. Naleway, Shaun J. Grannis, Malini B. DeSilva, Toan C. Ong, Manjusha Gaglani, Jungmi Han, Monica Dickerson, Bruce Fireman, Kristin Dascomb, Stephanie A. Irving, Gabriela Vazquez-Benitez, Suchitra Rao, Deepika Konatham, Palak Patel, Kristin E. Schrader, Ned Lewis, Nancy Grisel, Charlene McEvoy, Kempapura Murthy, Eric P. Griggs, Elizabeth A. K. Rowley, Ousseny Zerbo, Julie Arndorfer, Margaret M. Dunne, Kristin Goddard, Caitlin Ray, Yan Zhuang, Julius Timbol, Morgan Najdowski, Duck-Hye Yang, John Hansen, Sarah W. Ball, Ruth Link-Gelles
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 71:1637-1646
During June-October 2022, the SARS-CoV-2 Omicron BA.5 sublineage accounted for most of the sequenced viral genomes in the United States, with further Omicron sublineage diversification through November 2022.* Bivalent mRNA vaccines contain an ancestr
Autor:
Alexandra F Dalton, Zachary A Weber, Katie S Allen, Edward Stenehjem, Stephanie A Irving, Talia L Spark, Katherine Adams, Ousseny Zerbo, Victoria Lazariu, Brian E Dixon, Kristin Dascomb, Emily Hartmann, Anupam B Kharbanda, Toan C Ong, Malini B DeSilva, Maura Beaton, Manjusha Gaglani, Palak Patel, Allison L Naleway, Magdalene N S Kish, Shaun J Grannis, Nancy Grisel, Chantel Sloan-Aagard, Suchitra Rao, Chandni Raiyani, Monica Dickerson, Elizabeth Bassett, William F Fadel, Julie Arndorfer, Juan Nanez, Michelle A Barron, Gabriela Vazquez-Benitez, I Chia Liao, Eric P Griggs, Sarah E Reese, Nimish R Valvi, Kempapura Murthy, Elizabeth A K Rowley, Peter J Embi, Sarah Ball, Ruth Link-Gelles, Mark W Tenforde
Publikováno v:
Clinical Infectious Diseases. 76:1615-1625
Background Coronavirus disease 2019 (COVID-19) vaccination coverage remains lower in communities with higher social vulnerability. Factors such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure risk and access to healthcare are
Autor:
Malini B DeSilva, Patrick K Mitchell, Nicola P Klein, Brian E Dixon, Mark W Tenforde, Mark G Thompson, Allison L Naleway, Shaun J Grannis, Toan C Ong, Karthik Natarajan, Sarah E Reese, Ousseny Zerbo, Anupam B Kharbanda, Palak Patel, Edward Stenehjem, Chandni Raiyani, Stephanie A Irving, William F Fadel, Suchitra Rao, Jungmi Han, Sue Reynolds, Jonathan M Davis, Ned Lewis, Charlene McEvoy, Monica Dickerson, Kristin Dascomb, Nimish R Valvi, Michelle A Barron, Kristin Goddard, Gabriela Vazquez-Benitez, Nancy Grisel, Mufaddal Mamawala, Peter J Embi, Bruce Fireman, Inih J Essien, Eric P Griggs, Julie Arndorfer, Manjusha Gaglani
Publikováno v:
The Journal of Infectious Diseases. 227:961-969
Background We assessed coronavirus disease 2019 (COVID-19) vaccination impact on illness severity among adults hospitalized with COVID-19, August 2021–March 2022. Methods We evaluated differences in intensive care unit (ICU) admission, in-hospital
Autor:
Toan C. Ong, Michael G. Kahn, Bethany M. Kwan, Traci Yamashita, Elias Brandt, Patrick Hosokawa, Chris Uhrich, Lisa M. Schilling
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 17, Iss 1, Pp 1-12 (2017)
Abstract Background Electronic health records (EHRs) contain detailed clinical data stored in proprietary formats with non-standard codes and structures. Participating in multi-site clinical research networks requires EHR data to be restructured and
Externí odkaz:
https://doaj.org/article/195964f54c964b2896a97fdf7f602b39
Autor:
Ruth Link-Gelles, Matthew E. Levy, Manjusha Gaglani, Stephanie A. Irving, Melissa Stockwell, Kristin Dascomb, Malini B. DeSilva, Sarah E. Reese, I-Chia Liao, Toan C. Ong, Shaun J. Grannis, Charlene McEvoy, Palak Patel, Nicola P. Klein, Emily Hartmann, Edward Stenehjem, Karthik Natarajan, Allison L. Naleway, Kempapura Murthy, Suchitra Rao, Brian E. Dixon, Anupam B. Kharbanda, Akintunde Akinseye, Monica Dickerson, Ned Lewis, Nancy Grisel, Jungmi Han, Michelle A. Barron, William F. Fadel, Margaret M. Dunne, Kristin Goddard, Julie Arndorfer, Deepika Konatham, Nimish R. Valvi, J. C. Currey, Bruce Fireman, Chandni Raiyani, Ousseny Zerbo, Chantel Sloan-Aagard, Sarah W. Ball, Mark G. Thompson, Mark W. Tenforde
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 71:931-939
The Omicron variant (B.1.1.529) of SARS-CoV-2, the virus that causes COVID-19, was first identified in the United States in November 2021, with the BA.1 sublineage (including BA.1.1) causing the largest surge in COVID-19 cases to date. Omicron sublin
Autor:
Nicola P. Klein, Maria Demarco, Katherine E. Fleming-Dutra, Melissa S. Stockwell, Anupam B. Kharbanda, Manjusha Gaglani, Suchitra Rao, Ned Lewis, Stephanie A. Irving, Emily Hartmann, Karthik Natarajan, Alexandra F. Dalton, Ousseny Zerbo, Malini B. DeSilva, Deepika Konatham, Edward Stenehjem, Elizabeth A. K. Rowley, Toan C. Ong, Shaun J. Grannis, Chantel Sloan-Aagard, Jungmi Han, Jennifer R Verani, Chandni Raiyani, Kristin Dascomb, Sarah E. Reese, Michelle A. Barron, William F. Fadel, Allison L. Naleway, Juan Nanez, Monica Dickerson, Kristin Goddard, Kempapura Murthy, Nancy Grisel, Zacharay A. Weber, Brian E. Dixon, Palak Patel, Bruce Fireman, Julie Arndorfer, Nimish R. Valvi, Eric P. Griggs, Carly Hallowell, Peter J. Embi, Sarah W. Ball, Mark G. Thompson, Mark W. Tenforde, Ruth Link-Gelles
Publikováno v:
Pediatrics. 151
OBJECTIVES We assessed BNT162b2 vaccine effectiveness (VE) against mild to moderate and severe coronavirus disease 2019 (COVID-19) in children and adolescents through the Omicron BA.4/BA.5 period. METHODS Using VISION Network records from April 2021